Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Total Assets

₹575.31B

Quarterly · Period ending: · INR

RDY logo

RDY Total Assets

Latest reported₹575.31B INR
RDY Quarterly Total Assets · INR (₹15.39B → ₹575.31B)
High-resolution chart · PNG

RDY total assets history

Quarterly · INR. Dates are reporting period ends; fiscal years can differ from calendar years.

Dr. Reddy's Laboratories Ltd Common Stock Total Assets — Quarterly (INR)
Period endingTotal Assets (INR)
575,305,000,000
567,876,508,000
562,899,000,000
542,005,000,000
519,537,000,000
492,989,000,000
481,059,000,000
465,955,000,000
415,297,000,000
387,518,000,000
4,480,533,565
347,022,000,000
335,041,000,000
321,854,000,000
3,738,667,956
3,576,761,266
3,747,823,609
3,864,427,581
3,800,316,537
3,751,978,714
3,742,957,083
3,631,204,800
3,453,601,122
3,434,223,366
3,327,556,578
3,069,889,790
3,052,726,919
233,861,000,000
227,090,000,000
225,427,000,000
226,675,000,000
234,234,000,000
230,880,000,000
225,604,000,000
225,956,000,000
222,018,000,000
218,387,000,000
219,821,000,000
227,188,000,000
220,415,000,000
195,525,000,000
207,650,000,000
207,882,000,000
202,487,000,000
201,200,000,000
194,762,000,000
184,399,000,000
176,318,000,000
173,544,000,000
170,223,000,000
168,119,000,000
161,146,000,000
150,936,000,000
1,423,690,000,000
136,811,000,000
130,550,000,000
126,634,000,000
119,477,000,000
122,430,000,000
107,803,000,000
97,951,000,000
95,005,000,000
84,021,000,000
83,369,000,000
81,865,000,000
80,330,000,000
72,617,000,000
82,677,000,000
76,229,000,000
83,792,000,000
96,341,000,000
95,568,333,000
90,995,560,000
85,445,040,000
80,180,160,856
80,845,590,829
78,354,099,599
86,122,731,653
87,091,337,856
82,783,210,492
77,626,894,072
68,945,818,295
32,814,218,775
31,666,211,100
30,941,695,033
29,288,339,088
26,100,521,217
27,955,321,324
29,104,918,594
26,677,051,158
25,646,575,086
25,187,276,673
24,349,256,909
23,025,310,520
22,290,263,465
21,404,831,474
20,888,502,680
18,946,182,209
17,984,722,486
17,076,874,293
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.